Q Med Abseminariegatan 21uppsala S 752 7522 Pma Numberp140029 Supplement Numbers046 Date Received09 07 2022 Decision Date10 04 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Q Med Abseminariegatan 21uppsala S 752 7522 Pma Numberp140029 Supplement Numbers046 Date Received09 07 2022 Decision Date10 04 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P140029S046 Q-Med ABseminariegatan 21uppsala S-752-7522 PMA NumberP140029 Supplement NumberS046 Date Received09/07/2022 Decision Date10/04/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	RESTYLANE® Family of Injectable Gels	2022-10-04